Skip to main content

Yvonne S Ziegler

Research Scientist (PI: Dr. Benita S. Katzenellenbogen)

Additional Campus Affiliations

Research Specialist, Molecular and Integrative Physiology

Recent Publications

Kumar, S., Ziegler, Y., Plotner, B. N., Flatt, K. M., Kim, S. H., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (2024). Resistance to FOXM1 inhibitors in breast cancer is accompanied by impeding ferroptosis and apoptotic cell death. Breast Cancer Research and Treatment, 208(2), 307-320. https://doi.org/10.1007/s10549-024-07420-9

Min, C. K., Nwachukwu, J. C., Hou, Y., Russo, R. J., Papa, A., Min, J., Peng, R., Kim, S. H., Ziegler, Y., Rangarajan, E. S., Izard, T., Katzenellenbogen, B. S., Katzenellenbogen, J. A., & Nettles, K. W. (2024). Asymmetric allostery in estrogen receptor-α homodimers drives responses to the ensemble of estrogens in the hormonal milieu. Proceedings of the National Academy of Sciences of the United States of America, 121(24), Article e2321344121. https://doi.org/10.1073/pnas.2321344121

Guillen, V. S., Ziegler, Y., Gopinath, C., Kumar, S., Dey, P., Plotner, B. N., Dawson, N. Z., Kim, S. H., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (2023). Effective combination treatments for breast cancer inhibition by FOXM1 inhibitors with other targeted cancer drugs. Breast Cancer Research and Treatment, 198(3), 607-621. https://doi.org/10.1007/s10549-023-06878-3

Dey, P., Wang, A., Ziegler, Y., Kumar, S., Yan, S., Kim, S. H., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (2022). Estrogen Receptor Beta 1: A Potential Therapeutic Target for Female Triple Negative Breast Cancer. Endocrinology, 163(12), Article bqac172. https://doi.org/10.1210/endocr/bqac172

Zuo, Q., Mogol, A. N., Liu, Y. J., Casiano, A. S., Chien, C., Drnevich, J., Imir, O. B., Kulkoyluoglu-Cotul, E., Park, N. H., Shapiro, D. J., Park, B. H., Ziegler, Y., Katzenellenbogen, B. S., Aranda, E., O’Neill, J. D., Raghavendra, A. S., Tripathy, D., & Erdogan, Z. M. (2022). Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy. Molecular Cancer Research, 20(6), 923-937. https://doi.org/10.1158/1541-7786.MCR-21-0781

View all publications on Illinois Experts